EurekAlert! -
1 Sep 2014 06:00
(European Society of Cardiology) Roughly a decade since the start of telemonitoring capabilities in implantable cardiac defibrillators (ICDs), the first financial assessment of the impact of home monitored follow-up estimates the cost to physicians, hospitals and insurance providers is the same as traditional in-office monitoring, according to a new study.
Share this Article